Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,133
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Radiofrequency Ablation For Recurrent Parathyroid Carcinoma
for
Recurrent Parathyroid Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07475780
Recruiting
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
for
ALK-positive NSCLC, ALK-Positive Lung Cancer,
Location: Houston TX, Nashville TN, St Louis MO, Aurora CO,
Sponsor: TRIANA Biomedicines, Inc.
Sex: All
Age: 18+
Code: NCT07491497
Phase 1, Phase 2, Recruiting
Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders
for
Schizophrenia Spectrum Disorder
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 18 - 60
Code: NCT07290738
Recruiting
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
Location: Houston TX, Ann Arbor MI, Cleveland OH, Portland OR
Sponsor: Novelty Nobility, Inc.
Sex: All
Age: 18+
Code: NCT06805825
Phase 1, Recruiting
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
for
KRAS-mutant Non-small Cell Lung Cancer (NSCLC),
Location: Houston TX, San Antonio TX, Tampa FL, Sarasota FL,
Sponsor: Kestrel Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07458347
Phase 1, Recruiting
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT01371630
Phase 1, Phase 2, Recruiting
A Phase 1 Study of D3S-003 as Monotherapy in Participants With Advanced Solid Tumors With a KRAS p.G12D Mutation.
for
KRAS P.G12D
Location: Houston TX, San Antonio TX, New Haven CT
Sponsor: D3 Bio (Wuxi) Co., Ltd
Sex: All
Age: 18+
Code: NCT07456046
Phase 1, Recruiting
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
for
Solid Tumors
Location: Houston TX, San Antonio TX, Dallas TX, Denison TX,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07522073
Phase 3, Recruiting
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins
for
Neurofibromas, MPNST
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 1+
Code: NCT07298083
Recruiting
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
for
Colorectal Cancer
Location: Texas City TX, Florida City FL, Highlands Ranch CO,
Sponsor: Kahr Bio Australia Pty Ltd
Sex: All
Age: 18+
Code: NCT07235293
Phase 2, Recruiting
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
for
Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma
Location: Houston TX, Louisville KY, Plantation FL, Fairfax VA,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT07407933
Phase 1, Phase 2, Recruiting
A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia
for
Cytopenia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06285825
Phase 2, Recruiting
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
for
Chronic Lymphocytic Leukemia (CLL),
Location: Houston TX, Atlanta GA, Sarasota FL, Denver CO,
Sponsor: Nurix Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05131022
Phase 1, Recruiting
ASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
for
Acute Myeloid Leukemia, Myelodysplastic Syndrome,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05010122
Phase 1, Phase 2, Recruiting
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
for
Obesity or Overweight
Location: Bellaire TX, Houston TX, San Antonio TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07351045
Phase 3, Recruiting
Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment
for
Advanced or Metastatic Solid Tumor, Liver Failure
Location: Houston TX, San Antonio TX, Baltimore MD, Newark DE
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT04617522
Phase 1, Recruiting
Want a closer look at research in Houston? Read our guide: Clinical Trials in Houston: Why the City Leads the Country